Kedrion Biopharma is part of the 2026 International Plasma Protein Congress (IPPC), held in Milan, Italy, on April 28–29 under the organization of the Plasma Protein Therapeutics Association (PPTA). The Congress focuses this year on “Resilience, Reach & Responsibility: building a high-performing, patient-centric plasma ecosystem”. In line with this guiding theme, a large Kedrion delegation